Delivery Order SPE2DB22D2218-SPE2DB24FR2NJ
- Not listed
- This federal contract award was issued by the Department of Defense's Medical Supply Chain agency to Amerisourcebergen Drug Corp's Corporate Office Division. The $16,783.10 firm fixed price delivery order is for the supply of the pharmaceutical drug ANDEXXA 200 MG VIALS, with a completion date of June 7, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to $999,999,999.00 through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company AmerisourceBergen Corporation. The contract, valued at $21,709.01, is a firm fixed price delivery order for the pharmaceutical product ANDEXXA 200 MG VIALS. The contract has an ultimate completion date of April 22, 2024. AmerisourceBergen Drug Corp is the prime contractor on an Indefinite Delivery Contract (IDC) awarded by DLA with a potential value of...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of ANDEXXA 200 MG VIALS, a pharmaceutical product. The contract has a ceiling value of $16,783.10 and was awarded by the Medical Supply Chain, a component of the Department of Defense. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,931.53, is a delivery order for 4,568,075,871 vials of the medication ANDEXXA 200 MG. The contract is a firm fixed-price agreement with a period of performance ending on May 20, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of ANDEXXA 200 MG VIALS to the Defense Logistics Agency (DLA). The $16,783.10 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 8, 2024 and was awarded on October 18, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of ANDEXXA 200 MG VIALS, a pharmaceutical product, to be delivered by March 8, 2024. The contract is a firm fixed price delivery order with a potential value of $10,377.47. No set-aside designation was used for...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for ANDEXXA 200 MG VIALS. The $20,794.59 firm fixed price contract has a completion date of July 21, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this award. This delivery order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The U.S. federal government awarded a delivery order contract valued at $6,658.72 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is for the supply of ANDEXXA 200 MG VIALS, a pharmaceutical product. This contract is not set aside for any particular business type. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,344.30 firm fixed-price contract is for the delivery of ANDEXXA 200 MG VIALS, a pharmaceutical product, with a completion date of July 17, 2025. This contract is not set aside and was awarded on an open competitive basis. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This federal contract award, valued at $288,008.91, was issued to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, which has a July 16, 2024 completion date, was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- SPE2DB22D2218Indefinite Delivery Contract
- SPE2DB22D2218-SPE2DB24FR2NJDelivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of 200 mg vials of the pharmaceutical product ANDEXXA, with a ceiling value of $6,658.73. The award was made by the Defense Logistics Agency (DLA), a defense agency, under a Delivery Order contract type with a Firm Fixed Price pricing mechanism. The contract has an ultimate completion date of May 31, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific award does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 5/9/24 |